Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · IEX Real-Time Price · USD
3.560
-0.060 (-1.66%)
At close: Apr 22, 2024, 3:59 PM
3.690
+0.130 (3.65%)
After-hours: Apr 22, 2024, 7:12 PM EDT

Tenax Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2000
Revenue
000000000.050.29
Upgrade
Revenue Growth (YoY)
---------82.93%-76.60%
Upgrade
Cost of Revenue
0000000000.13
Upgrade
Gross Profit
000000000.050.16
Upgrade
Selling, General & Admin
5.015.687.585.315.085.655.686.257.1713.77
Upgrade
Research & Development
3.235.3825.154.563.471.243.5313.146.663
Upgrade
Other Operating Expenses
000000033.271.030
Upgrade
Operating Expenses
8.2311.0532.739.878.566.899.2152.6514.8716.77
Upgrade
Operating Income
-8.23-11.05-32.73-9.87-8.56-6.89-9.21-52.65-14.82-16.61
Upgrade
Interest Expense / Income
0.0200000000.052.21
Upgrade
Other Expense / Income
-0.55-0.01-0.25-0.02-0.167.25-0.37-0.76-0.780.72
Upgrade
Pretax Income
-7.71-11.05-32.47-9.85-8.39-14.14-8.84-51.89-14.08-19.54
Upgrade
Income Tax
0000000-7.9600
Upgrade
Net Income
-7.71-11.05-32.47-9.85-8.39-14.14-8.84-43.92-14.08-19.54
Upgrade
Preferred Dividends
0000000005.8
Upgrade
Net Income Common
-7.71-11.05-32.47-9.85-8.39-14.14-8.84-43.92-14.08-25.35
Upgrade
Shares Outstanding (Basic)
0000000000
Upgrade
Shares Outstanding (Diluted)
0000000000
Upgrade
Shares Change
1250.92%43.00%98.50%67.33%295.91%10.88%0.34%0.23%199.32%432.73%
Upgrade
EPS (Basic)
-31.04-600.71-2524.80-1520.00-2160.00-14464.00-10032.00-49984.00-16000.00-86720.00
Upgrade
EPS (Diluted)
-31.04-600.71-2524.80-1520.00-2160.00-14464.00-10032.00-49984.00-16000.00-86720.00
Upgrade
Free Cash Flow
-5.9-11.39-10.86-9.28-7.56-5.51-12.15-15.8-9.75-9.27
Upgrade
Free Cash Flow Per Share
-23.75-619.37-844.54-1431.84-1952.34-5631.03-13775.46-17979.26-11107.97-31690.18
Upgrade
Gross Margin
--------100.00%55.04%
Upgrade
Operating Margin
---------30062.78%-5753.25%
Upgrade
Profit Margin
---------28571.63%-8778.29%
Upgrade
Free Cash Flow Margin
---------19775.45%-3211.13%
Upgrade
EBITDA
-7.68-10.93-32.36-9.74-8.29-14.14-8.83-51.87-13.88-17.18
Upgrade
EBITDA Margin
---------28171.47%-5949.95%
Upgrade
Depreciation & Amortization
0.010.110.110.110.110.010.010.020.150.15
Upgrade
EBIT
-7.69-11.04-32.47-9.85-8.39-14.14-8.84-51.89-14.03-17.33
Upgrade
EBIT Margin
---------28472.04%-6002.08%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).